1. Academic Validation
  2. Cloning and characterization of human urocortin

Cloning and characterization of human urocortin

  • Endocrinology. 1996 May;137(5):2167-70. doi: 10.1210/endo.137.5.8612563.
C J Donaldson 1 S W Sutton M H Perrin A Z Corrigan K A Lewis J E Rivier J M Vaughan W W Vale
Affiliations

Affiliation

  • 1 Clayton Foundation Laboratories for Peptide Biology, Salk Institute, La Jolla 92037, USA.
Abstract

Urocortin, a new member of the CRF peptide family which also includes urotensin I and sauvagine, was recently cloned from the rat midbrain. The synthetic replicate of urocortin was found to bind with high affinity to type 1 and type 2 CRF receptors and, based upon its anatomic localization within the brain, was proposed to be a natural ligand for the type 2 CRF receptors. Using a genomic library, we have cloned the human counterpart of rat urocortin and localized it to human chromosome 2. Human and rat urocortin share 95% identity within the mature peptide region. Synthetic human urocortin binds with high affinity to CRF receptor types 1, 2 alpha, and 2 beta, stimulates cAMP accumulation from cells stably transfected with these receptors, and acts in vitro to release ACTH from dispersed rat anterior pituitary cells. In addition, the CRF-binding protein binds human urocortin with high affinity and can prevent urocortin-stimulated ACTH secretion in vitro. The inhibitory effect of the CRF-binding protein on human urocortin can be blocked by biologically inactive CRF fragments, such as CRF(9-33).

Figures